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a-Defensins are a family of mammalian antimicrobial peptides that exhibit variable activity against a panel of microbes,
including bacteria, fungi, and enveloped viruses. We have employed a maximum-likelihood approach to detect evidence
of positive selection (adaptive evolution) in the evolution of these important molecules of the innate immune response.
We have identified 14 amino acid sites that are predicted to be subject to positive selection. Furthermore, we show that all
these sites are located in the mature antimicrobial peptide and not in the prepropeptide region of the molecule, implying
that they are of functional importance. These results suggest that mammalian a-defensins have been under selective
pressure to evolve in response to potentially infectious challenges by fast-evolving microbes.
Introduction
Defensins are cationic antimicrobial peptides that
show a broad spectrum of antimicrobial activity against
gram-negative and gram-positive bacteria, fungi, and
enveloped viruses. They are generally thought to act by
disrupting the membrane integrity of microbes (Kagan
et al. 1990; Satchell et al. 2003). In mammals, a-defensins
and b-defensins are two structurally distinct groups, which
differ in size and in their spacing of a six-cysteine motif. a-
Defensins were first discovered as a family of peptides in
rabbit macrophages (Selsted, Szklarek, and Lehrer 1984)
and were subsequently identified in the neutrophils of
humans, macaques, rats, rabbits, guinea pigs, and hamsters
and in human and mouse small intestine Paneth cells (Raj
and Dentino 2002).
In humans, six a-defensins have been identified and
studied to date. Human a-defensins 1 to 4 are localized in
azurophilic granules of neutrophils, which has led to them
being referred to as human neutrophil peptides (HNP1 to
HPN4). The HNPs are the most abundant protein in
neutrophils and contribute to the oxygen-dependent killing
of phagocytosed microorganisms (Ganz et al. 1985; Singh
et al. 1988; Bateman et al. 1991). Recently, HNP1 to
HPN3 have been shown to be the major components of
a soluble factor secreted from CD8 T-lymphocytes that
suppresses HIV-1 replication (Zhang et al. 2002). Human
a-defensins (HAD) 5 and 6 are primarily located in the
secretory granules of Paneth cells within the crypts of
Lieberku¨hn in the small intestine (Jones and Bevins 1992,
1993; Porter et al. 1997; Salzman et al. 2003b) where they
have been implicated in mucosal host defense. Further
evidence for the important role these peptides play in
mucosal host defense has been shown in a recent study in
which transgenic mice expressing HAD5 were completely
resistant to Salmonella typhimurium (Salzman et al.
2003b). HAD5 has also been detected in female re-
productive tract (Svinarich et al. 1997; Quayle et al. 1998)
and in bronchial and nasal epithelia (Frye et al. 2000).
Peptides homologous to HAD5 and HAD6 have been
found in mouse Paneth cells where they are termed
cryptdins (Ouellette et al. 1992, 1994).
a-Defensins are encoded as propeptides that require
proteolytic processing to become activated. It has been
suggested that the proregion is cytoprotective because
addition of it to in vitro assays inhibit activity (Ouellette et al.
1999; Wu et al. 2003). Paneth cell trypsin has been identified
as the processing enzyme for HAD5, but the processing
enzyme for HAD6 has yet to be identified (Ghosh et al.
2002). In mice, activation of cryptdins is mediated by matrix
metalloproteinase-7 (MMP-7) (Wilson et al. 1999; Ayabe
et al. 2002). The signal peptide and proregion in a-defensins
exhibit more amino acid conservation than does the mature
antimicrobial peptide region. Indeed only the six cysteine
residues and a glycine residue at position 18 of the mature
peptide are conserved between all a-defensins. These
residues are important for the structure of the molecule
(Hill et al. 1991), whereas the other residues are free to vary.
Most molecular variation either within species or
between species is caused by the random fixation of
mutations that are neutral. Mutations that are deleterious
to an organism are removed by purifying selection.
Occasionally, mutations confer selective advantage to the
organisms having them, and, therefore, these mutations are
fixed in the population by positive selection (adaptive
evolution) at a higher rate than expected under neutral
evolution. One of the most stringent methods of detecting
adaptive evolution is to compare the rate of nonsynonymous
substitutions (dN) with the rate of synonymous substitution
(dS). The ratio between these rates (x ¼ dN/dS) is then
a reliable measure of the selective pressure acting in
a protein-coding gene. If amino acid changes are neutral,
they will be fixed at the same rate as synonymous mutations
(x¼1). If mutations (dN) are deleterious, dN/dS¼0, and the
mutations will be removed by selection. If nonsynonymous
mutations are slightly deleterious x is less than 1, and the
coefficient of selection acting against the mutation will
depend on the population size. Finally, if the amino acid
changes are selectively advantageous, they will be fixed at
a higher rate (x . 1). A number of methods have been
developed to calculate dN and dS among lineages (see for
review, Yang [2002]). Maximum-likelihood (ML) methods
are most statistically satisfactory because they employ an
explicit model of evolution, taking into account the effects
of unequal transition and transversion rates, unequal base
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and codon frequencies, and variable x values among
lineages in a phylogeny (Yang 1998; Yang and Nielsen
1998). As most amino acid sites are expected to be
conserved to maintain key structural and functional
characteristics of a protein, and only a small number of
sites in a protein are likely to be affected by adaptive
evolution, methods that average substitution rates over all
sites in a sequence have little power in detecting cases of
positive selection. Apart from models that detect positive
selection among lineages, models that can detect amino
acids sites under adaptive evolution have also been
developed (Nielsen and Yang 1998; Yang et al. 2000).
Because a-defensins are a critical component of the
innate immune response in an ‘‘arms race’’ against fast-
evolving microbes, it is possible that these molecules are
subject to adaptive evolution. It has been previously
demonstrated that x is greater than 1 in the antimicrobial
peptide region of a-defensins, indicative of positive
selection (Hughes and Yeager 1997). The Hughes and
Yeager study was, however, unable to predict which
particular amino acid sites were under positive selection,
as appropriate models were undeveloped at that time. In
this first comprehensive study of all available mammalian
a-defensins, we implement ML models to test for positive
selection among evolutionary lineages and among amino
acid sites.
Materials and Methods
Coding sequences and corresponding protein se-
quences for 34 a-defensins from seven different species,
Homo sapiens (human), Macaca mulatta (rhesus monkey),
Mus musculus (mouse), Rattus norvegicus (rat), Orycto-
lagus cuniculus (rabbit), Cavia porcellus (domestic guinea
pig), and Cavia cutleri (wild guinea pig) were downloaded
from GenBank (table 1). These sequences represent all the
full-length a-defensins currently available in the database.
Molecules annotated as a-defensin–related were not
included in this study, as they contain a different cysteine
motif in the mature peptide and do not align well in this
region with other a-defensins. Inclusion of these molecules
could bias the results by overestimating dN. The protein
sequences were aligned using the T-Coffee program (fig. 1
in Supplementary Material online) (Notredame, Higgins,
and Heringa 2000). A Neighbor-Joining (NJ) tree was
inferred from the protein alignment using MEGA version
2.1, with the gamma distribution model implemented to
account for heterogeneity among sites (Kumar et al. 2001).
The shape parameter of the gamma distribution (a) was
estimated using the BASEML program (implementing the
REV model) from the PAML package version 3.12 (Yang
1997). One-thousand bootstrap replicates were carried out
to test the significance of each node in the tree. Branches
leading to nodes with a bootstrap value of less than 500
were collapsed. The topology of the tree was used as the
input tree for CODEML and CODEMLSITES programs,
also from the PAML package version 3.12 (Yang 1997).
To construct an alignment of the coding sequences, the
protein alignment was used as a template, and a copygaps
Perl script was used to align the DNA, maintaining the
gaps that were present in the protein alignment. Any
columns in the DNA alignment that had more than three
gaps were removed.
Variable Selective Pressures Among Lineages
Models of variable x ratios among lineages were
fitted by ML to the alignment of the 34 a-defensin
sequences. The one-ratio model assumes an equal x ratio
for all branches in the phylogeny. The free-ratios model
assumes an independent x ratio for each branch. The two
models can be compared by a likelihood ratio test (LRT).
Twice the log-likelihood difference between the two
models is compared with a v2 distribution with N-1
degrees of freedom where N is the number of branches.
Posterior Bayesian probabilities were estimated for codon
substitutions in each branch of the phylogenetic tree.
Variable Selective Pressures Among Amino Acid Sites
Models of variable x ratios among sites were used to
test for the presence of sites under diversifying selection
(x . 1) and to identify them. Five models for the x
distribution implemented in the CODEMLSITES program
of the PAML package were tested. Model M1 (neutral)
assumes two classes of sites in the protein: the conserved
Table 1
Accession Numbers of the 34 a-Defensin Genes Used in
the Analyses
Gene Species Accession Number
HNP1 Homo sapiens NM_004084
HNP3 Homo sapiens NM_005217
HNP4 Homo sapiens NM_001925
HAD5 Homo sapiens NM_021010
HAD6 Homo sapiens NM_001926
MNP1 Macaca mulatta AF184159
MNP1A Macaca mulatta AF184160
MNP2 Macaca mulatta AF184161
Mdef1 Macaca mulatta AF188268
Mdef3 Macaca mulatta AF188269
Mdef4 Macaca mulatta AF188271
Mdef6 Macaca mulatta AF188272
Mdef8 Macaca mulatta AF188270
CRP1 Mus musculus NM_010031
CRP2 Mus musculus U02996
CRP3 Mus musculus NM_007850
CRP4 Mus musculus NM_010039
CRP5 Mus musculus NM_007851
CRP6 Mus musculus NM_007852
NP1 Rattus norvegicus U16686
NP2 Rattus norvegicus NM_173329
NP3 Rattus norvegicus U50353
NP3B Rattus norvegicus U50354
ED Rattus norvegicus AF115768
NP4 Rattus norvegicus NM_173299
NP3A Oryctolagus cuniculus M64599
NP4 Oryctolagus cuniculus M64601
NP5 Oryctolagus cuniculus M64602
MCP1 Oryctolagus cuniculus M28883
MCP2 Oryctolagus cuniculus M28072
DEF1A Cavia porcellus D14119
DEF1B Cavia porcellus D14118
DEF2 Cavia porcellus X63676
DEF1A Cavia cutleri X57705
NOTE.—Where RefSeq (http://www.ncbi.nlm.nih.gov/RefSeq/) accession num-
bers have been assigned, these have been used, otherwise, GenBank accession
numbers are given.
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sites (x ¼ 0) and the neutral sites (x ¼ 1). Model M2
(selection) adds a third class of site, with x as a free
parameter, allowing for sites with x greater than 1. Under
the discrete model M2, the proportion of sites under
purifying selection (p0) and proportion of sites under
neutrality (p1) are estimated from the data. Model M3
(discrete) uses a general discrete distribution with three
classes of site, with the proportions (p0, p1, and p2) and the
x ratios (x0, x1, and x2). Model M7 (beta) uses a beta
distribution, which, depending on parameters p and q, can
take different shapes in the interval (0, 1). Model M8 (beta
and x) adds an extra class of sites to the beta (M7) model,
with the proportion and the x ratio estimated from the data,
thus allowing for sites with x greater than 1. From these
models, three LRTs compare M0 (one ratio) with M3
(discrete), M1 (neutral) with M2 (selection), and M7 (beta)
with M8 (beta and x), respectively. Models M2, M3, and
M8 are tests of positive selection among sites. Posterior
Bayesian probabilities of site classes were calculated for
each amino acid site. If the x ratios for some site classes
are greater than 1, sites with high posterior probabilities for
those classes are likely to be under positive selection.
Sliding-Window Analysis to Detect Selective
Constraints by Maximum Parsimony
Several studies have shown that maximum-likelihood
methods are sensitive to the violation of assumptions made
in models to detect adaptive evolution and that false
positive results could be obtained under certain conditions
(Suzuki and Nei 2002). We, therefore, applied a maximum-
parsimony method to test for adaptive evolution in our
sequences. We applied the Kimura-based model of Li
(1993) using a sliding-window procedure (Fares et al.
2002). Briefly, the method infers a statistically optimum
codon-window size and slides it along the alignment. We
then test in each sliding step the significance of the
nonsynonymous nucleotide substitutions (dS), synonymous
substitutions (dN), and the nonsynonymous-to-synonymous
rate ratio (x). The mathematical approach used is based on
the maximum-parsimony method of Suzuki and Gojobori
(1999). The main difference however resides in the fact that
the window size is selected under a statistical procedure
(Fares et al. 2002). Another advantage of using this method
is that the number of synonymous substitutions is tested for
significance, and, hence, saturated synonymous sites, if
any, can be highlighted and removed from the analysis.
Results
An NJ phylogenetic tree was reconstructed from the
amino acid alignment using MEGA version 2.1 (fig. 1). The
gamma distribution model was implemented to account for
heterogeneity among sites (Kumar et al. 2001). The gamma
shape parameter was estimated using the BASEML
program to be a ¼ 1.39. This tree topology was used in
the subsequent analyses to detect adaptive evolution. To
ensure that the topology of the tree was not dependent on
the sites under positive selection or the invariant sites, the
phylogenetic analysis was repeated without these sites. The
topology of this tree was essentially the same as the tree in
figure 1, with some of the resolution lost (see Supplemen-
tary Material online). The CODEMLSITES analysis was
repeated using this topology as input and resulted in the
detection of the same sites as being subject to positive
selection (data not shown).
Multigene families whose members have the same
function may evolve in a concerted fashion that homog-
enizes the sequences of the member genes by interlocus
recombination or gene conversion, such that sequences
within a species are more similar to each other than those
between species (Liao 1999). The physical clustering
typical of a-defensin families within species may imply
concerted evolution. There are, however, two exceptions
to phylogenetic clustering in our tree (fig. 1), which may
mean that the birth-and-death model of evolution is more
appropriate (Nei, Gu, and Sitnikova 1997). Neither the
primates nor the rodents show species-specific clades of a-
defensins. In fact, in the case of the mouse and rat, the
FIG. 1.—Neighbor-Joined tree of mammalian a-defensins. Con-
structed using MEGA version 2.1 (gamma distribution model, 1,000
bootstrap replicates). Branches with less than 50% bootstrap support have
been collapsed. Mm ¼ Mus musculus (mouse), Rn ¼ Rattus norvegicus
(rat), Hs ¼ Homo sapiens (human), Mma ¼ Macaca mulatta (rhesus
monkey), Oc ¼ Oryctolagus cuniculus (rabbit), Cp ¼ Cavia porcellus
(domestic guinea pig), and Cc ¼ Cavia cutleri (guinea pig).
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phylogenetic clustering appears to be caused by a func-
tional relationship between the different a-defensins. Mice
do not have neutrophil defensins (Eisenhauer and Lehrer
1992) and most of the rat a-defensins are expressed in
neutrophils; however, the one rat a-defensin expressed in
the intestine (ED_Rn) in a similar manner to the mouse
cryptdins, clusters with the mouse a-defensins. Further-
more, the level of sequence divergence, even at the protein
level (fig. 1 in supplementary material available online), is
inconsistent with the homogenization of sequences
expected under the concerted evolution model. In the
birth-and-death model of evolution, duplicate genes are
produced in a gene family. Some of the genes functionally
diverge, others may be lost from the genome, and still
others become pseudogenes (Liao 1999). Consistent with
this model, we have detected multiple a-defensin pseudo-
genes in the human and mouse genomes (unpublished
data).
Examining Saturation of Synonymous Sites
Saturation of synonymous sites is an important issue
in the detection of positive selection by the criterion that
dN/dS is greater than 1, as saturation will lead to the
underestimation of dS and an inflation of the dN/dS ratio.
To ensure that saturation was not an issue in our data set,
pairwise dN and dS values were calculated using the ML
method implemented by CODEML (Goldman and Yang
1994). A correlation analysis between dN and dS was
performed using SPSS version 11.0 (fig. 2). If synony-
mous sites are saturated, we might expect a quadratic
model with an increasing slope to be better fit to the data
than a linear model. If synonymous sites are not saturated,
a linear model should fit the data better than a quadratic
model. A quadratic model with a decreasing slope implies
that when average values of nonsynonymous nucleotide
substitutions are examined, most of them show strong
purifying selection and no saturation of synonymous sites
exists in our data that could inflate dN/dS values.
Variable Selective Pressures Among Lineages
To test for variable x ratios among lineages, the one-
ratio model (Goldman and Yang 1994), which assumes the
same x ratio for all lineages, was compared with the free-
ratio model (Yang 1998), which assumes an independent
x ratio for each branch, using the LRT. The log-likelihood
value for the one-ratio model is ‘0 ¼23888.76, while the
value for the free-ratio model is ‘1 ¼ 23862.20.
Comparison of 2‘ ¼ 2(‘1 2 ‘0) ¼ 53.12 (df ¼ 60)
reveals that the free-ratio model is not significantly better
than the one-ratio model (P . 0.5). The free-ratio model
does, however, predict variable x values among lineages,
some of which are greater than 1 (fig. 3). Because the LRT
did not reveal a significant difference, we cannot conclude
that there is evidence of positive selection among the a-
defensin lineages. The relatively low x values in some of
the mouse lineages may be a result of the fact that all the
mouse a-defensins are expressed only in the intestine and
not in the neutrophils (Eisenhauer and Lehrer 1992), and
as a group they may not be subject to the same selective
pressures as the other species that have both neutrophil and
intestine a-defensins.
Variable Selective Pressures Among Amino Acid Sites
To test for positive selection at individual amino acid
sites, LRTs were carried out between model M0 (one ratio)
and M3 (discrete), M1 (neutral) and M2 (selection), and
M7 (beta) and M8 (beta and x) (table 2). All 3 models
(M2, M3 and M8) that allow for selection (table 3) are
significantly favored over the other models (P , 0.001) in
all cases (table 3). The sites predicted to be under positive
selection with posterior probabilities greater than 0.95 are
in agreement between models M2, M3 and M8, except for
FIG. 2.—Correlation between dN and dS values as estimated by maximum likelihood.
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sites 25 and 62. Neither of these sites is predicted by M8,
and site 25 is only predicted by M3.
a-Defensins are encoded as prepropeptides that are
proteolytically cleaved to release the C-terminal anti-
microbial peptide. All of the sites predicted to be under
positive selection under model M8, the most stringent
model, are located in the mature antimicrobial peptide and
not in the prepropeptide region (fig. 4a). Comparison of
the distribution of positively selected sites to a Poisson
distribution revealed that the clustering of these sites in the
antimicrobial peptide was statistically significant (P ,
0.001). Adaptive evolution of the mature peptide is likely
to have driven the considerable amino acid variation in this
region compared with the prepropeptide region.
The sites predicted to be subject to positive selection
have been displayed on the three-dimensional structure of
HNP3 (fig. 4b). Although sites under positive selection
occur throughout the molecule, it is notable that almost all
of the sites in the coil region (residues 7 to 14) are subject
to adaptive evolution. The only site not predicted is Glu14,
which is known to form a salt bridge with Arg6 and as
such is relatively invariable (Hill et al. 1991). It is likely
that this region has an important part to play in the
function and activity of the antimicrobial peptide.
Many of the sites detected to be under positive
selection using ML-based models were also detected using
the sliding-window–based method. Some others, however
(amino acid sites 62, 63, 68, 69, 78, and 82), did not show
significant differences between dS and dN. Among the
positive-selected amino acid sites, the average x value was
2.972, being significantly higher than 1 and higher than
the expectation under neutrality, even after correcting for
multiple tests (multiple sliding-window tests) using
Bonferroni correction (Z ¼ 11.47; P , 0.001). We have
not detected saturation of synonymous sites and hence x
values are not inflated by this bias. We have to stress,
however, that maximum-parsimony methods are very
conserved and may be subject to the problem of possible
convergences. Despite this fact, our results using maxi-
mum parsimony are quite coincident with those using ML
methods and do not affect the final conclusions of this
study.
FIG. 3.—Phylogeny of mammalian a-defensins. The abbreviations used are the same as in figure 1. Branch lengths were estimated by maximum
likelihood under the free-ratio model, which assumes an independent x value for each branch. Branches with no x values shown had values¼ ‘. x
values greater than 1 are shown in bold. The topology and number of branches is the same as in figure 1 (some branches are very short and are not
visible on this tree).
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FIG. 4.—Sites predicted to be under positive selection in mammalian a-defensins. (a) Sites predicted to be under positive selection are highlighted
in the multiple sequence alignment and (b) the dimer structure of the mature HNP3 peptide (PDB entry¼ 1DFN). Sites shown in red are those sites
predicted to be under positive selection (model 8). Posterior probabilities for these sites are all greater than 0.95. Sites shown in blue are the sites that are
100% conserved across all OTUs. The mature antimicrobial peptide for HNP3 is highlighted. The mature peptides for other a-defensins may differ in
size slightly at either terminus. The numbering of residues in the mature peptide of HNP3 in (a) corresponds to the numbering assigned to the HNP3
structure in the Protein Data Bank (PDB) database (http://www.rcsb.org/pdb/) (b). Note that residue 2 in (a) and (b) corresponds to residue 63 in table 3,
and so on. The structure of HNP3 was displayed using RasMol version 2.7.2.1(http://www.openrasmol.org/software/rasmol/).
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Discussion
In this study, we have detected positive selection at
several amino acid sites located in the active antimicrobial
peptide region of a-defensins. It is likely that as mammals
evolved to occupy new niches, they were faced with a new
range of microbial pathogens. Evolution of antimicrobial
peptides with new sensitivities capable of targeting novel
infectious agents would confer a selective advantage. Our
results are consistent with adaptive evolution of the a-
defensins in response to such a challenge and the evolution
of specificity for different microbes. There is experimental
evidence that a-defensin peptides are diverse in their
potency against different pathogens. The human neutrophil
defensins HNP1, HNP2, and HNP3 are not active against
the oral gram-negative bacterium Actinobacillus actino-
mycetemcomitans (Miyasaki et al. 1990a), whereas rabbit
NP-1 shows strong activity (Miyasaki et al. 1990b).
Trophozoites of Giardia lamblia are very sensitive to
mouse cryptdins 2 and 3 but not to cryptdins 1 and 6 (Aley
et al. 1994). Notably, the giardicidal activity has been
attributed to the presence of a positively charged arginine
residue at position 15 in the active peptide (Ouellette and
Bevins 2001). In our study, this site is predicted to be
under adaptive evolution. Rat and rabbit defensins have
also been shown to have variable activities against a panel
of gram-positive and gram-negative bacteria (Kohashi
et al. 1992).
Small changes in the primary structure of these
molecules can have enormous effect on their potency.
HNP1 and HNP3 differ only by one residue at the N-
terminus of the mature peptide, and, yet, HNP1 exhibits
potent activity against Candida albicans, whereas HNP3
has little effect. (Lehrer et al. 1988; Raj, Antonyraj, and
Karunakaran 2000). This site was also predicted to be
subject to positive selection in our study. Similarly, the
activity of mouse cryptdin 4, the most potent of the mouse
a-defensins against a broad spectrum of microbes
(Ouellette et al. 1994), is dependent on the presence of
one or two residues at the N-terminus of the active
peptide. Removal of these residues can totally eliminate
the antimicrobial activity of cryptdin 4 (Ouellette et al.
2000).
It is probable that the evolution of different
mechanisms of interaction with microbial membranes has
been important in the evolution of specificity of particular
a-defensins for particular microbes. Human HNP2 forms
stable multimeric pores in model membranes (Wimley,
Selsted, and White 1994), whereas rabbit NP-1 does not,
but permeabilizes membranes by creating large, short-
lived defects (Hristova, Selsted, and White 1996). These
alternative mechanisms are likely to have varying effects,
depending on the constitution of the membrane, which is
variable among microbes.
Many microbes have evolved mechanisms that
attempt to evade and subvert the actions of antimicrobial
molecules (Ganz 2001). It is likely that this ongoing ‘‘arms
race’’ with microbes has been a significant force driving
the adaptive evolution of the a-defensins. For example, the
human pathogens, Pseudomonas aeruginosa, Enterococ-
cus faecalis, and Streptococcus pyogenes release dermatan
sulphate, a compound that binds to and neutralizes HNP1
(Schmidtchen, Frick, and Bjorck 2001). Furthermore, the
pathogen Salmonella enterica can elicit a decrease in the
expression of mouse cryptdins (Salzman et al. 2003a).
In this study we have provided evidence that several
amino acid sites in the active peptide of mammalian a-
defensins are under positive Darwinian evolution. This
work will assist in the design of in vitro analyses of
functionally and structurally relevant sites. By syntheti-
cally changing the residues at sites predicted to be under
positive selection, which are the sites most likely to be of
functional importance, it is possible to alter the activity of
these molecules against particular pathogens and gain
insight into their mechanisms of activity.
Positive selection in the mature antimicrobial region
of other antimicrobial peptide families has also been
demonstrated. Evidence of positive selection has been
detected in primate b-defensins (Boniotto et al. 2003;
Semple, Rolfe, and Dorin 2003), murine b-defensins
(Morrison et al. 2003), the Drosophila andropin antibac-
Table 2
Evidence of Adaptive Evolution Among Sites in Mammalian a-Defensins
Model P Parameters ‘ dN/dS Positively Selected Sites
M0: one ratio 1 x ¼ 0.9342 23888.76 ¼ x
M1: neutral 1 p0 ¼ 0.108, x0 ¼ 0 23837.45 0.8918
p1 ¼ 0.892, x1 ¼ 1
M2: selection 3 p0 ¼ 0.107, x0 ¼ 0 23751.88 1.6211 62,63,68,69,70,72,73,74,77,78,82,84,86,87,89
p1 ¼ 0.670, x1 ¼ 1
p2 ¼ 0.223, x2 ¼ 4.263
M3: discrete 5 p0 ¼ 0.188, x0 ¼ 0.075 23740.19 1.264 25,62,63,68,69,70,72,73,74,77,78,82,84,86,87,89
p1 ¼ 0.585, x1 ¼ 0.821
p2 ¼ 0.227, x2 ¼ 3.386
M7: beta 2 p ¼ 0.479, q ¼ 0.273 23797.38 0.6374
M8: beta and x 4 p0 ¼ 0.791, p ¼ 0.452, q ¼ 0.230 –3738.80 1.258 63,68,69,70,72,73,74,77,78,82,84,86,87,89
p1 ¼ 0.209, x ¼ 3.513
Table 3
Likelihood Ratio Test (LRT) to Detect Adaptive Evolution
Models 2‘ v2 Value df P-value
M1 versus M2 2(–3837.45 23751.88) 171.14 2 ,0.001
M0 versus M3 2(–3888.76 23740.19) 297.14 4 ,0.001
M7 versus M8 2(–3797.38 23738.80) 117.16 2 ,0.001
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terial peptide (Date-Ito et al. 2002), and in a number of
amphibian antimicrobial peptides (Duda, Vanhoye, and
Nicolas 2002). The detection of positive selection in these
important modulators of the innate immune response
provides evidence that despite the evolution of the
adaptive immune response in jawed vertebrates more than
450 MYA, the innate immune response continues to
function as a critical element in host defense.
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